Company Overview: Pivot Pharma

Industry News

26 May

Pivot Pharmaceuticals To Present at the 5th Annual SeeThruEquity Microcap Investor Conference in New York City on May 31, 2016

BOSTON, MA and VANCOUVER, BC / ACCESSWIRE / May 26, 2016 / Pivot Pharmaceuticals Inc. (PVOTF) (“Pivot” or the “Company”), an emerging biotechnology company engaged in the development of therapeutics to address unmet medical needs in women’s health, today announced that the company will present at the 5th Annual SeeThruEquity Microcap Investor...

Read more

15 Mar

Pivot Pharmaceuticals Announces Blue Sky Compliance

BOSTON, MA and VANCOUVER, BC–(Marketwired – Mar 15, 2016) –  Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), an emerging biotechnology company engaged in the development of therapeutics to address unmet medical needs in women’s health, is pleased to announced that Blue Sky Monitoring Service has completed its audit and reports...

Read more

29 Feb

Pivot Pharmaceuticals Provides Shareholder Update

BOSTON, MA and VANCOUVER, BC–(Marketwired – Feb 29, 2016) – Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), an emerging biotechnology company engaged in the development of therapeutics to address unmet medical needs in women’s health, is pleased to provide the following shareholder update.  Pivot has had a very busy start...

Read more

10 Dec

Pivot Pharmaceuticals Strengthens Scientific Advisory Board

BOSTON, MA and VANCOUVER, BC–(Marketwired – Dec 10, 2015) –  Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), an emerging biotechnology company engaged in the development of therapeutics to address unmet medical needs in women’s health including oncology and urology, is pleased to announce the appointments of Steven Grossman, M.D., Ph.D.,...

Read more

23 Nov

Pivot Pharmaceuticals Completes Acquisition of IndUS Pharmaceuticals

Dr. Pravin Chaturvedi Appointed CEO of Combined Pivot-IndUS Entity BOSTON, MA and VANCOUVER, BC–(Marketwired – Nov 23, 2015) –  Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), an emerging biotechnology company engaged in the development of therapeutics to meet unmet medical needs in women’s health, is pleased to announce that the...

Read more

5 Nov

Pivot Pharmaceuticals to Acquire IndUS Pharmaceuticals

BOSTON, MA and VANCOUVER, BC–(Marketwired – Nov 5, 2015) – Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), an emerging biotechnology company engaged in the development of therapeutics to meet unmet medical needs in women’s health, is pleased to announce that the Company has signed a Definitive Agreement to acquire IndUS...

Read more

13 Oct

Pivot Pharmaceuticals Inc. Announces PCG Advisory Group as Agency of Record

VANCOUVER, BC and NEW YORK, NY–(Marketwired – Oct 13, 2015) –  Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), an emerging biotechnology company engaged in the development of therapeutics to meet unmet medical needs in women’s health, is pleased to announce today they have engaged leading investor relations firm PCG Advisory...

Read more

5 Oct

Pivot Pharmaceuticals Up-Lists to OTCQB(R) Venture Marketplace

BOSTON, MA and VANCOUVER, BC–(Marketwired – Oct 5, 2015) – Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) (“Pivot” or the “Company”), an emerging biotechnology company engaged in the development of therapeutics to meet unmet medical needs in women’s health, is pleased to announce that the Company’s stock has been up-listed to the OTCQB® Venture...

Read more

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address